- P-ISSN 1010-0695
- E-ISSN 2288-3339
Objective:This study aimed to investigate the effects of SHD on myelosuppression using an animal model for therapeutic evidence supporting clinical positive results. Methods:After determining the optimal concentration of 5-FU as 300 ㎎/㎏ for developing the mouse model, ICR mice or BALB/c mice were administered with SHD, and several blood parameters, including hematopoietic cytokines, colony forming activity and histological findings, were examined to evaluate the effects. Results:SHD restored the WBC and hemoglobin, and showed effects on maintaining body weight, producing GM-CSF and IL-3 and stem cell colony forming activity in accordance with histological relative entirety on bone marrow. Conclusion:SHD is an herbal drug having therapeutic effects on myelosuppression. Thus, it could be prescribed to cancer patients undergoing chemo-therapies or radio-therapies in the process of cancer treatment.